Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.14.5 extracted from

  • Vora, K.; Porter, G.; Peng, R.; Cui, Y.; Pryor, K.; Eiermann, G.; Zaller, D.
    Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses (2009), BMC Immunol., 10, 19.
    View publication on PubMedView publication on EuropePMC

Inhibitors

Inhibitors Comment Organism Structure
(R)-3-amino-4-(2,5-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one
-
Mus musculus
additional information selective inhibition of DPP-IV does not impair T dependent immune responses to antigenic challenge Mus musculus

Organism

Organism UniProt Comment Textmining
Mus musculus
-
-
-

Synonyms

Synonyms Comment Organism
CD26
-
Mus musculus
dipeptidyl peptidase IV
-
Mus musculus
DPP-IV
-
Mus musculus

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.000027
-
-
Mus musculus (R)-3-amino-4-(2,5-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one

General Information

General Information Comment Organism
malfunction DPP-IV knockout mice have no major differences in the leukocytes populations in spleen, thymus and blood as compared to their wild type controls Mus musculus